戻る Agenda
Payer Collaborations with Pharma: Real-world Evidence to Improve Patient Outcomes and Influence the Pipeline
Session Chair(s)
Christopher Marrone, PHARMD, RPH
Outcomes Liaison Advisor – National Accounts, Value, Evidence and Outcomes (VEO)
Eli Lilly and Company, United States
This session will focus on the objectives and outcomes of payer/pharmaceutical real-world evidence collaborations. Speakers will include pharmaceutical representatives and payers sharing their goals, vision, and experiences of their collaborations.
Learning Objective : Define collaborations, in terms of payer/pharma relationships; Describe current collaborations between payers and pharmaceutical companies; Explain the rationale, benefits and outcomes of collaborations between payers and pharmaceutical companies.
Speaker(s)
Collaborations Overview and the Pharma Perspective
James Harnett, PHARMD, MS
Regeneron Pharmaceuticals, Inc. , United States
Executive Director, Health Economics and Outcomes Research
The Payer Perspective: National Managed Care Experience
Steve Chick
inVentiv Health, United States
Collaborations: A National Payer Experience
Joseph Singer
HealthCore Inc., a subsidiary of WellPoint Inc., United States
Vice President, Clinical Affairs